Some links may earn us a commission; our work is independent.

eXciteOSA Review: Our 3-Month First-Hand Test for Snoring

Our three-month eXciteOSA test tracks SnoreLab results, daily-use comfort, salivation, app timing, mouthpiece replacement costs, and the limits of one person's outcome.

eXciteOSA product image

Our verdict

After three months, our tester's SnoreLab score was lower and the daytime routine felt easier than it had initially. Those are useful individual observations, not a controlled demonstration of sleep-apnea treatment efficacy. Prescription suitability, restrictive session timing, and recurring mouthpiece costs are central to the purchase decision.

A daytime routine
The reviewed protocol involved one 20-minute session while awake each day, rather than equipment worn during sleep.
Easier with continued use
Our tester found the early stimulation and salivation difficult, but both became more manageable over the three-month trial.
One tester's tracking result
The SnoreLab score moved from 63 to 40 by the end, with an illness-related spike in between. This was not a controlled sleep-apnea study.
Recurring mouthpiece expense
The recorded replacement schedule was three months from first use. That adds an ongoing cost even if the mouthpiece still looks intact.

The short version

  • One tester used eXciteOSA for three months and kept a daily journal alongside SnoreLab tracking.
  • The final recorded snore score was lower, but a consumer app result is not an AHI measurement or proof of treatment efficacy.
  • Comfort improved after the early stimulation and salivation issues; the app's once-daily timing remained restrictive.
  • This is a prescription-context device with ongoing mouthpiece costs; suitability needs guidance from a sleep professional.

How we reviewed it

One tester used eXciteOSA for three months and kept a daily-use journal alongside SnoreLab tracking. The record supports this tester’s comfort, usability, and snoring experience, but it is not a controlled AHI study and cannot predict another patient’s medical outcome.

eXciteOSA is a daytime therapy device designed to reduce snoring and improve mild obstructive sleep apnea by using neuromuscular electrical stimulation (NMES) to train the tongue while you are awake. Instead of wearing equipment at night, you complete a short daily session during the day. Over time, the goal is that improved tongue muscle function helps keep the airway more open during sleep, which can reduce snoring and support easier breathing.

Our tester used eXciteOSA for three months and tracked snore scores and sleep health trends alongside a running journal. Below is what it was like to use, what changed over time, and who we think the device is best for.

Design and setup

What’s in the box

picture of eXciteOSA in the box

The package includes the essentials to start therapy right away:

  • eXciteOSA device (controller): The main unit that powers and controls stimulation.

  • Mouthpiece: The intraoral component that delivers stimulation to the tongue. The manufacturer recommends replacing it after three months from first use.

  • Connection cable (device-to-mouthpiece): This lets you connect the controller to the mouthpiece using a cable rather than attaching the mouthpiece directly. We found this genuinely helpful because it kept saliva away from the main device during sessions, which made the routine feel cleaner and less fussy.

  • Charging cable: Used to recharge the controller.

Who it suits

Consider it if

eXciteOSA may be a strong match if you:

  • Snore consistently and want an option that does not require wearing a mask or oral appliance during sleep.

  • Prefer daytime therapy and can commit to a short, consistent daily routine.

  • Have mild obstructive sleep apnea and are exploring options with guidance from a sleep professional.

Keep looking if

You may want to consider other options if you:

  • Have moderate or severe obstructive sleep apnea, or suspect you do. eXciteOSA is not intended for AHI 15 or higher. 1

  • Want a one-time purchase with minimal ongoing expenses.

The daytime routine

How eXciteOSA works

During each session, eXciteOSA delivers neuromuscular stimulation to the tongue through an intraoral mouthpiece. The stimulation is meant to activate and train tongue muscles. In theory, better tongue tone reduces the chance of the tongue relaxing backward during sleep and contributing to airway narrowing and vibration, which can influence snoring and breathing quality.

The manufacturer’s protocol is 20 minutes once daily, and improvements are expected to build gradually over several weeks.

Setup and comfort

The first sessions felt intense

In the beginning, the electrical stimulation could be uncomfortable at higher intensity levels. Our tester described the sensation as strong enough that it took some experimentation to find a tolerable level.

Over the following weeks, that changed in a noticeable way. Our tester could use higher intensity levels more comfortably, and settings that initially felt intense became barely noticeable over time. For us, this was one of the clearest signs that the experience becomes easier with consistency.

Salivation was the biggest early hurdle

The other major early adjustment was salivating. During the first stretch of use, our tester needed a napkin on hand and sometimes paused to dry the mouthpiece and keep the session comfortable.

By around the two-month mark, the salivation issue eased substantially. Sessions could be completed without tissues and without frequent pauses. That improvement made the overall routine feel far more manageable.

Our Results After 3 Months

We tracked snore scores throughout the testing period. Here is the broad pattern from our testing journal.2

SnoreLab progress chart throughout the eXciteOSA testing
period

Pre-therapy starting point

  • Starting snore score: 63

This served as our initial reference point for comparison.

Mid-therapy update: a spike during illness

In November and December, we saw a rise in snore scores:

  • Snore score rose to: 97 and 111

This period included about two weeks when our reviewer had the flu, which likely affected breathing comfort and snoring due to congestion and irritation. We think it is important context for interpreting the temporary spike.

Final results: noticeable improvement

After that period, the snore score dropped significantly:

  • Snore score later dipped to: 40

Compared to the starting point of 63, ending at 40 reflects a 23-point reduction, or about a 37% improvement. We also saw the improvement line up with our tester’s notes describing easier breathing during sleep and fewer disruptive snoring nights.

What we liked

Daytime therapy model

For people who dislike nighttime equipment, the simple fact that you use eXciteOSA while awake is a real advantage. It can feel easier to build into a routine than something you must wear during sleep.

The experience improved as we stuck with it

Intensity tolerance improved steadily, and the early salivation issue faded with time. By later weeks, sessions felt more predictable and less disruptive.

Measurable snoring improvement by the end of the trial

Even with an illness-related spike mid-way through, the later score drop to 40 was the most important marker for us, and it matched the subjective reports of better breathing comfort during sleep.

Helpful cable design

We appreciated having a connection cable that allowed the mouthpiece to be used without saliva directly contacting the main controller. In day-to-day use, that detail made sessions feel cleaner and helped reduce the need to constantly wipe down the device.

Ownership and tradeoffs

Mouthpiece replacement can raise total cost over time

The mouthpiece is recommended to be replaced after three months from first use.

In our experience, the mouthpiece still looked and functioned like new with careful maintenance, but the replacement schedule still applies. Over the long term, that could significantly increase the total cost of ownership, which may be a drawback for some shoppers.

App timing can feel strict

The app limited sessions to once per day, which became inconvenient if a session happened after midnight and you wanted to use the device again later the next day. It is not a deal-breaker, but it is a real-world friction point that can affect routine consistency.

Final verdict

In our three-month test, eXciteOSA delivered the main outcome we were hoping for. Snoring improved by the end of the trial, and our tester reported easier breathing during sleep. The learning curve was real at first, especially with sensation strength and salivation, but those issues improved with time and did not remain the defining part of the experience.

For adults with snoring or mild obstructive sleep apnea who want a daytime routine and can commit to consistent sessions, eXciteOSA may be worth considering. It is less compelling for anyone who needs maximum flexibility or is sensitive to ongoing replacement costs.

Sources

Evidence cited in this article.

2 sources
  1. FDA 510(k) summary for eXciteOSA — intended use and AHI context (opens in a new tab)
    U.S. Food and Drug AdministrationGovernment source
    ↩
  2. Sleepiverse three-month testing journal and SnoreLab tracking, including starting and ending scores, illness-period readings, comfort observations, and daily-use notes.
    Reference
    ↩